Financhill
Back

Brainstorm Cell Therapeutics Stock Predictions

Brainstorm Cell Therapeutics Stock Forecast

  • Is Brainstorm Cell Therapeutics Stock Undervalued?
    The current Brainstorm Cell Therapeutics [BCLI] share price is $0.38. The Score for BCLI is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Brainstorm Cell Therapeutics Stock Go Up Next Year?

Data Unavailable

Brainstorm Cell Therapeutics Stock Rating

Data Unavailable

Brainstorm Cell Therapeutics Stock Price History

Is BCLI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
brainstorm-cell.com

52-Week Data

52-Week High:
3.34
52-Week Low:
0.13

Prediction Charts

Market Cap:
25.97M
Price in USD:
0.38
Volume:
539.43K
Beta:
0.58

Technical Analysis

SMA50:
0.48
SMA100:
0.39
SMA200:
0.60
52-Wk Change:
-87.66%

Stock Predictions

  • Is Brainstorm Cell Therapeutics stock public?
    Yes, Brainstorm Cell Therapeutics is a publicly traded company.
  • What is the Brainstorm Cell Therapeutics stock quote today?
    The Brainstorm Cell Therapeutics stock price is 0.38 USD today.
  • How to buy Brainstorm Cell Therapeutics stock online?
    You can buy Brainstorm Cell Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 0.52 0.53 0.57 0.45
Apr-17 0.53 0.54 0.59 0.53
Apr-18 0.56 0.51 0.59 0.45
Apr-19 0.50 0.53 0.61 0.45
Apr-22 0.54 0.54 0.58 0.51
Apr-23 0.54 0.53 0.56 0.51
Apr-24 0.52 0.55 0.56 0.52
Apr-25 0.55 0.53 0.56 0.52
Apr-26 0.55 0.53 0.56 0.52
Apr-29 0.54 0.54 0.55 0.52
Apr-30 0.54 0.38 0.56 0.36
May-1 0.44 0.43 0.54 0.41
May-2 0.45 0.40 0.46 0.36
May-3 0.39 0.38 0.43 0.37

Brainstorm Cell Therapeutics Earnings

Data Unavailable

Brainstorm Cell Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.

* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.